. (2018). Reply to: No effect of resistance-associated substitutions in patients with rare HCV subtypes following treatment with sofosbuvir-containing regimens. Journal Of Hepatology. https://doi.org/10.1016/j.jhep.2017.11.044 (Original work published 2018)
P Richardson
First name:
P
Last name:
Richardson
. (2018). A platform for automated nanomole-scale reaction screening and micromole-scale synthesis in flow. Science (New York, N.y.), 359(6374), 429-434. https://doi.org/10.1126/science.aap9112 (Original work published 2018)
. (2018). ACG Clinical Guideline for Alcoholic Liver Disease: The MELD Threshold for Corticosteroid Treatment has Yet to be Established. The American Journal Of Gastroenterology. https://doi.org/10.1038/s41395-018-0076-x (Original work published 2018)
. (2018). Reply to: "The long-term prognosis of alcoholic hepatitis is poor and independent of disease severity for patients surviving an acute episode". Journal Of Hepatology, 68(6), 1332. https://doi.org/10.1016/j.jhep.2018.02.023
. (2018). Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis. Journal Of Hepatology, 68(3), 511-518. https://doi.org/10.1016/j.jhep.2017.11.017
. (2017). The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS). Frontline Gastroenterology, 8(4), 243-251. https://doi.org/10.1136/flgastro-2016-100792
. (2017). In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA. Gastroenterology, 152(5), 1068-1077.e4. https://doi.org/10.1053/j.gastro.2016.12.019
. (2021). Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. The New England Journal Of Medicine, 385(7), 595-608. https://doi.org/10.1056/NEJMoa2101016 (Original work published 2021)
